Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Arcutis Biotherapeutics (ARQT)
NASDAQ:ARQT
RESEARCH TOOLSreports
Holding ARQT?
Track your performance easily
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Nov 26, 2024 | Patrick Burnett Reporting Person's Title: Svp Chief Medical Officer | xxxxxxxxxxxxx | $162473 |
| Nov 19, 2024 | Masaru Matsuda Reporting Person's Title: Svp Gc And Corporate Secretary | xxxxxxxxxxxxx | $17182 |
| Nov 18, 2024 | Patrick Burnett Reporting Person's Title: Svp Chief Medical Officer | xxxxxxxxxxxxx | $712310 |
| Nov 13, 2024 | Terrie Curran Director | xxxxxxxxxxxxx | $94167 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Sep 30, 2024 | xxxxxxxxxxxxx | $165298 | |
| Sep 30, 2024 | xxxxxxxxxxxxx | $207259 | |
| Sep 30, 2024 | xxxxxxxxxxxxx | $12634050 | |
| Sep 30, 2024 | xxxxxxxxxxxxx | $33050693 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 6,125,950 | Institution | 5.23% | 91,827,991 | |
| 4,867,706 | Insider | 5.20% | 72,966,913 | |
| 5,195,518 | Institution | 4.44% | 77,880,815 | |
| 5,180,369 | Institution | 4.43% | 77,653,731 | |
| 3,553,838 | Institution | 3.04% | 53,272,032 | |
| 3,085,198 | Institution | 2.64% | 46,247,118 | |
| 3,070,801 | Institution | 2.62% | 46,031,307 | |
| 2,735,010 | Institution | 2.34% | 40,997,800 | |
| 1,525,545 | Institution | 1.30% | 22,867,920 | |
| 1,358,500 | Institution | 1.16% | 20,363,915 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 5,195,518 | Institution | 4.44% | 77,880,815 | |
| 3,085,198 | Institution | 2.64% | 46,247,118 | |
| 2,735,010 | Institution | 2.34% | 40,997,800 | |
| 1,525,545 | Institution | 1.30% | 22,867,920 | |
| 1,190,372 | Institution | 1.02% | 17,843,676 | |
| 1,105,897 | Institution | 0.94% | 16,577,396 | |
| 1,072,979 | Institution | 0.92% | 16,083,955 | |
| 903,900 | Institution | 0.77% | 13,549,461 | |
| 538,084 | Institution | 0.46% | 8,065,879 | |
| 490,568 | Institution | 0.42% | 7,353,614 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,972,444 | Institution | 2.54% | 44,556,936 | |
| 2,396,656 | Institution | 2.05% | 35,877,940 | |
| 3,520,666 | Institution | 3.01% | 29,256,734 | |
| 978,733 | Institution | 0.84% | 14,671,208 | |
| 1,601,085 | Institution | 1.37% | 13,305,016 | |
| 750,031 | Institution | 0.64% | 11,242,965 | |
| 673,421 | Institution | 0.58% | 10,094,581 | |
| 508,178 | Institution | 0.43% | 7,607,425 | |
| 289,025 | Institution | 0.25% | 4,166,451 | |
| 483,238 | Institution | 0.41% | 4,015,708 |
FAQ
Who Owns Arcutis Biotherapeutics (ARQT)?
Currently, no data Available
What percentage of Arcutis Biotherapeutics (ARQT) stock is held by institutional investors?
Currently, no data Available
What percentage of Arcutis Biotherapeutics (ARQT) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of Arcutis Biotherapeutics (ARQT)?
Vanguard owns the most shares of Arcutis Biotherapeutics (ARQT).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.